ArticleJCO precision oncology2025

Risk Assessment With Ultra-Low-Pass Whole-Genome Sequencing of Cell-Free DNA for Large B-Cell Lymphoma.

Davidson Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.